KCT0000080已完成未知
A Placebo-controlled, Double-blind, Randomized, Multi-center, Phase II study for adult patients who need Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to evaluate efficacy and safety of Wemate® (Zinc Acexamate) regarding prevention of small bowel's erosion induced by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Kuhnil Pharm0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •1. Male or female patient who is 18 ~ 80 years old by Korean age
- •2. Patient who has given freely written informed consent to participate in this trial
- •3. Osteoarthritis or rheumatic arthritis patient who needs medication of NSAIDs at least 1 month or more
- •4. Less than 5 small bowels' erosion in capsule endoscopy at screening period
- •5. Patient who was found no significant enteropathy in capsule endoscopy at screening period
- •6. Patient who was found no significant gastropathy in gastroscopy at screening period
排除标准
- •1)Patient who has ulcer (except of scar) in gastro or/and small intestine 2)Patient who has hemorrhage (include hemorrhagic gastritis) or history of NSAIDs associated hemorrhage before 3)Patient who has reflux esophagitis of B, C, D group by LA classification 4)Patient who was made the diagnosis or R/O of enterostenosis totaly 5)Patient who has been gastrectomy before 6)Patient who is having Cancer in digestive system 7)Patient who has cardiovascular disease 8)Pathent who has been or expects to CABG less than 6 months from Visit 1 9)Patient who has been taken anti-uncer agent , H2 receptor antagonist, muscarinic receptor antagonist, aspirin, defensive factor elevating agent, TNF antagonist, Metronidazole, Sulfasalazine or drug maybe influence on NSAIDs or gastrointestinal motility 10)Pregnant (if she is on childbearing period, the result of HCG urine test should be positive) or breast-feeding woman 11)Childbearing woman who does not agree with appropriate contraception during trial period (appropriate contraception: contraceptive, sterile operation-vasectomy and tubal ligation, contraceptive device, condom, spermicide etc.) 12)Patient who had the value of Hb<10g/dl(female), <11g/dl(male) at screening blood hematology 13)Renal failure patient who had double value of Cr than upper normal range at screening blood chemistry 14)Hepatic failure patient who had double value of AST/ALT than upper normal range at screening blood chemistry 15)Asthma patient who could have possibility of increasing asthma symptom or occurring cnidosis or acute rhinitis caused by aspirin or another prostaglandin synthetase inhibitor 16)Patient who has been had hypersensitiveness related to Zinc or NSAID same as agent of this trial’s IP before 17)Patient who has been had alcohol abuse or drug misuse 18)Patient who received another IP within 4 weeks before registration 19)Other patients who are considered to be unsuitable for this trial by investigators or sub-investigator
研究者
相似试验
招募中
1 期
A Study of PNB-001 (Test, Manufactured by PNB Vesper Life Science Pvt. Ltd., India).CTRI/2019/12/022266PNB Vesper Life Science Pvt Ltd
已完成
2 期
A Double-blind, Placebo-controlled, Randomized, Multicenter Proof-of-principle Trial of Adjunctive Minocycline for Patients With Treatment-Resitant Unipolar Major Depressive Disorder (MDD)F32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDRKS00009444Charité - Universitätsmedizin Berlin, Sponsorvertretung: Frau Prof. Dr. Dipl.-Psych. Isabella Heuser173
进行中（未招募）
1 期
A Double-blind, Placebo-controlled, Randomized, Multicenter Proof-of-principle Trial of Adjunctive Minocycline for Patients With Treatment Resistant Unipolar Major Depressive Disorder (MDD)EUCTR2015-001456-29-DECharité - Universitätsmedizin Berlin160
进行中（未招募）
1 期
A Study of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)Primary Sjogren's SyndromeMedDRA version: 21.0Level: LLTClassification code 10040766Term: Sjogren's diseaseSystem Organ Class: 100000004859EUCTR2021-000665-32-ITJANSSEN CILAG INTERNATIONAL NV150
尚未招募
2 期
A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)Primary Sjögren's Syndromchronicprogressive autoimmune disease10003816NL-OMON52271Janssen-Cilag4